CompuGroup Medical (0MSD) Share Forecast & Price Target

Compare

3 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0MSD Analyst Ratings

Moderate Buy

2 Buy

0 Hold

0 Sell

Based on 2 analysts giving stock ratings to

CompuGroup

Medical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0MSD Stock 12 Month Forecast

Average Price Target

€24.50

▲(1.66%Upside)

Based on 2 Wall Street analysts offering 12 month price targets for CompuGroup Medical in the last 3 months. The average price target is €24.50 with a high forecast of €29.00 and a low forecast of €20.00. The average price target represents a 1.66% change from the last price of €24.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"€12","21":"€21","30":"€30","16.5":"€16.5","25.5":"€25.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€29.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€24.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€20.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,16.5,21,25.5,30],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.3,23.73846153846154,24.176923076923078,24.615384615384617,25.053846153846155,25.492307692307694,25.93076923076923,26.369230769230768,26.807692307692307,27.246153846153845,27.684615384615384,28.123076923076923,28.56153846153846,{"y":29,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.3,23.392307692307693,23.484615384615385,23.576923076923077,23.66923076923077,23.76153846153846,23.853846153846153,23.946153846153848,24.03846153846154,24.130769230769232,24.223076923076924,24.315384615384616,24.407692307692308,{"y":24.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.3,23.046153846153846,22.79230769230769,22.53846153846154,22.284615384615385,22.03076923076923,21.776923076923076,21.523076923076925,21.26923076923077,21.015384615384615,20.76153846153846,20.50769230769231,20.253846153846155,{"y":20,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.52,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.8,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.81,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.2,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.26,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.74,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.6,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.82,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.09,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.52,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.63,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.3,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€29.00

Average Price Target€24.50

Lowest Price Target€20.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Knut WollerBaader Bank

Baader Bank

€29

Buy

20.33%

Upside

Reiterated

07/15/25

Baader Bank Reaffirms Their Buy Rating on CompuGroup Medical (0MSD)

Unknown AnalystKepler Capital

Not Ranked

Kepler Capital

€20

Buy

-17.01%

Downside

Reiterated

06/24/25

Kepler Capital Remains a Buy on CompuGroup Medical (0MSD)

Fabian PiastaJefferies

Jefferies

€22

Hold

-8.71%

Downside

Reiterated

03/04/25

Cautious Outlook for CompuGroup Medical Amid Declining EBITDA and Strategic Uncertainties

Laura MetayerMorgan Stanley

Morgan Stanley

€25→€22

Hold

-8.71%

Downside

Reiterated

01/14/25

Compugroup medical SE (COP:GR) PT Lowered to EUR22 at Morgan StanleyMorgan Stanley analyst Laura Metayer lowered the price target on Compugroup medical SE (COP:GR) to EUR22.00 (from EUR25.00) while maintaining a Equalweight rating.

Wolfgang SpechtBerenberg Bank

Berenberg Bank

€21→€22

Hold

-8.71%

Downside

Downgraded

12/09/24

CompuGroup Medical (0MSD) was downgraded to a Hold Rating at Berenberg Bank

Andreas WolfWarburg Research

Warburg Research

€31→€24.5

Buy

1.66%

Upside

Reiterated

12/06/24

Simon KellerHauck & Aufhaeuser

Hauck & Aufhaeuser

€10

Sell

-58.51%

Downside

Downgraded

12/04/24

CompuGroup Medical (0MSD) was downgraded to a Sell Rating at Hauck & Aufhaeuser

Yannik SieringStifel Nicolaus

Stifel Nicolaus

€18

Hold

-25.31%

Downside

Downgraded

11/28/24

CompuGroup Medical Downgraded to Hold: Challenges in Software Sales and Project Execution Limit Recovery Prospects

Nicolas HermsDeutsche Bank

Deutsche Bank

€16

Hold

-33.61%

Downside

Reiterated

11/08/24

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Knut WollerBaader Bank

Baader Bank

€29

Buy

20.33%

Upside

Reiterated

07/15/25

Baader Bank Reaffirms Their Buy Rating on CompuGroup Medical (0MSD)

Unknown AnalystKepler Capital

Not Ranked

Kepler Capital

€20

Buy

-17.01%

Downside

Reiterated

06/24/25

Kepler Capital Remains a Buy on CompuGroup Medical (0MSD)

Fabian PiastaJefferies

Jefferies

€22

Hold

-8.71%

Downside

Reiterated

03/04/25

Cautious Outlook for CompuGroup Medical Amid Declining EBITDA and Strategic Uncertainties

Laura MetayerMorgan Stanley

Morgan Stanley

€25→€22

Hold

-8.71%

Downside

Reiterated

01/14/25

Wolfgang SpechtBerenberg Bank

Berenberg Bank

€21→€22

Hold

-8.71%

Downside

Downgraded

12/09/24

CompuGroup Medical (0MSD) was downgraded to a Hold Rating at Berenberg Bank

Andreas WolfWarburg Research

Warburg Research

€31→€24.5

Buy

1.66%

Upside

Reiterated

12/06/24

Simon KellerHauck & Aufhaeuser

Hauck & Aufhaeuser

€10

Sell

-58.51%

Downside

Downgraded

12/04/24

CompuGroup Medical (0MSD) was downgraded to a Sell Rating at Hauck & Aufhaeuser

Yannik SieringStifel Nicolaus

Stifel Nicolaus

€18

Hold

-25.31%

Downside

Downgraded

11/28/24

CompuGroup Medical Downgraded to Hold: Challenges in Software Sales and Project Execution Limit Recovery Prospects

Nicolas HermsDeutsche Bank

Deutsche Bank

€16

Hold

-33.61%

Downside

Reiterated

11/08/24

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CompuGroup Medical

1 Month

xxx

Success Rate

25/49 ratings generated profit

Average Return

-0.52%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 51.02% of your transactions generating a profit, with an average return of -0.52% per trade.

3 Months

xxx

Success Rate

25/49 ratings generated profit

Average Return

+0.70%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 51.02% of your transactions generating a profit, with an average return of +0.70% per trade.

1 Year

Knut WollerBaader Bank

Success Rate

27/49 ratings generated profit

Average Return

-2.48%

reiterated a buy rating 7 days ago

Copying Knut Woller's trades and holding each position for 1 Year would result in 55.10% of your transactions generating a profit, with an average return of -2.48% per trade.

2 Years

xxx

Success Rate

25/49 ratings generated profit

Average Return

-8.72%

reiterated a xxx

rating 7 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 51.02% of your transactions generating a profit, with an average return of -8.72% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0MSD Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0MSD has received 4 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 0MSD average Analyst price target in the past 3 months is 24.50.

Each month's total comprises the sum of three months' worth of ratings.

0MSD Financial Forecast

0MSD Earnings Forecast

Next quarter’s earnings estimate for 0MSD is €0.36 with a range of €0.36 to €0.36. The previous quarter’s EPS was €0.35. 0MSD beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.08% of the time in the same period. In the last calendar year 0MSD has Outperformed its overall industry.

0MSD Sales Forecast

Next quarter’s sales forecast for 0MSD is €285.50M with a range of €285.50M to €285.50M. The previous quarter’s sales results were ―. 0MSD beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.43% of the time in the same period. In the last calendar year 0MSD has Outperformed its overall industry.

0MSD Stock Forecast FAQ

What is GB:0MSD’s average 12-month price target, according to analysts?

Based on analyst ratings, CompuGroup Medical SE’s 12-month average price target is 24.50.

What is GB:0MSD’s upside potential, based on the analysts’ average price target?

CompuGroup Medical SE has 1.66% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CompuGroup Medical SE a Buy, Sell or Hold?

CompuGroup Medical SE has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.

What is CompuGroup Medical SE’s share price target?

The average share price target for CompuGroup Medical SE is 24.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €29.00 ,and the lowest forecast is €20.00. The average share price target represents 1.66% Increase from the current price of €24.1.

What do analysts say about CompuGroup Medical SE?

CompuGroup Medical SE’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

How can I buy shares of CompuGroup Medical SE?

To buy shares of GB:0MSD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

CompuGroup Medical (0MSD) Share Forecast & Price Target

0MSD Analyst Ratings

0MSD Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering CompuGroup Medical

0MSD Analyst Recommendation Trends

0MSD Financial Forecast

0MSD Earnings Forecast

0MSD Sales Forecast

0MSD Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts